An update of phase I data from RTOG 0211: A phase I/II clinical study of ZD 1839 (Gefitinib) plus radiation for newly diagnosed glioblastoma (GBM) patients

被引：0
|
作者：
Chakravarti, A
Seiferheld, W
Robins, HI
Guha, A
Brachman, D
Curran, W
Choucair, A
Mehta, M
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Amer Coll Radiol, Philadelphia, PA USA
[3] Univ Wisconsin, Madison, WI USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Fdn Canc Res, Phoenix, AZ USA
[6] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[7] LDS Hosp, Salt Lake City, UT USA
来源：
NEURO-ONCOLOGY | 2004年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [31] A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)
    Alexander, Brian M.
    Wang, Meihua
    Yung, W. K. Alfred
    Fine, Howard A.
    Donahue, Bernadine A.
    Tremont, Ivo W.
    Richards, Ray S.
    Kerlin, Kevin J.
    Hartford, Alan C.
    Curran, Walter J.
    Mehta, Minesh P.
    JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (01) : 33 - 39
  • [32] PHASE I STUDY OF RUXOLITINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GRADE III GLIOMAS AND GLIOBLASTOMA
    Rauf, Yasmeen
    Hufsey, Rachel
    Robinson, Kathy
    Suh, John
    Chao, Samuel
    Murphy, Erin
    Yu, Jennifer
    Peereboom, David
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2021, 23 : 69 - 69
  • [33] A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)
    Brian M. Alexander
    Meihua Wang
    W. K. Alfred Yung
    Howard A. Fine
    Bernadine A. Donahue
    Ivo W. Tremont
    Ray S. Richards
    Kevin J. Kerlin
    Alan C. Hartford
    Walter J. Curran
    Minesh P. Mehta
    Journal of Neuro-Oncology, 2013, 111 : 33 - 39
  • [34] Phase I/randomized phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed glioblastoma multiforme (GBM): Final results of phase I study.
    Laack, Nadia N.
    Galanis, Evanthia
    Leinweber, Clinton
    Buckner, Jan C.
    Giannini, Caterina
    Geoffroy, Francois J.
    Jaeckle, Kurt A.
    Sarkaria, Jann Nagina
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] PHASE I STUDY OF RUXOLITINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GRADE III GLIOMAS AND GLIOBLASTOMA
    Rauf, Yasmeen
    Hufsey, Rachel
    Robinson, Kathy
    Suh, John
    Chao, Samuel
    Murphy, Erin
    Yu, Jennifer
    Peereboom, David
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2020, 22 : 51 - 51
  • [36] RTOG 0913: A phase I study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
    Chinnaiyan, Prakash
    Won, Minhee
    Wen, Patrick Y.
    Rojiani, Amyn
    Wendland, Merideth M.
    DiPetrillo, Thomas A.
    Corn, Benjamin W.
    Mehta, Minesh P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] A phase II study of anlotinib combined with STUPP regimen in the treatment of patients with newly diagnosed glioblastoma (GBM).
    Li, Peijing
    Chen, Yuan Yuan Yuan
    Lai, Shuzhen
    Jiang, Fagui
    Liu, Xiaohui
    Tao, Changjuan
    Wang, Lei
    Liu, Guihong
    Huang, Jing
    Tang, Yiqiang
    Liu, Zhigang
    Shen, Guoping
    Li, Chaoming
    Xie, Tieming
    Lu, Fangxiao
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] RESULTS OF PHASE I OF THE PARADIGM TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH SHORT COURSE RADIOTHERAPY IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Chalmers, Anthony
    Stobo, Jon
    Short, Susan C.
    Herbert, Christopher
    Saran, Frank
    Morris, Anna
    Dillon, Susan
    Kelly, Caroline
    NEURO-ONCOLOGY, 2017, 19 : 5 - 5
  • [39] Phase I/pharmacokinetic study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma
    Butowski, Nicholas
    Lamborn, Kathleen
    Chang, Susan
    Page, Margaretta
    Rabbitt, Jane
    Federoff, Anne
    Parvataneni, Rupa
    Nicol, Steven
    Musib, Luna
    Liepa, Astra
    Thornton, Donald
    Prados, Michael
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3345S - 3345S
  • [40] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    James, Allan
    McBain, Catherine
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    NEURO-ONCOLOGY, 2018, 20 : 20 - 20
12345